Putylone (also known as β-keto-1,3-benzodioxolyl-N-propyldioxybutanamine, bk-PBDB, and N-propylbutylone) is a stimulant and empathogen compound detected in 2023,[1] around the time of a ban on the related compound eutylone.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H19NO3 |
Molar mass | 249.310 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Legal status
editThe specific legal status of putylone has not yet been addressed by any agency or government.
Putylone is likely considered illegal in jurisdictions where similar analogues or psychoactive substances bans are in place, such as in the US, UK, and Ireland.
See also
editReferences
edit- ^ Dixon DI, Millea MF, Wilcock AT, Costello A, Ellison JR, Lord S, O'Brian KA, Mewis RE, Sutcliffe OB (September 2023). "Synthesis, characterisation and quantification of the new psychoactive substance 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one (bk-PBDB, putylone)". Forensic Chemistry. 35: 100523. doi:10.1016/j.forc.2023.100523. ISSN 2468-1709. S2CID 260833005.